Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SSO 2024 Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
X
Xiao, Shu
UT Southwestern
P66: CTLA-4 Blockade Increases Tumor-infiltrating CD8+ Cells in a Syngeneic Model of Gastric Cancer
Location:C110
Shu Xiao
Xu, Alexander
Cedars-Sinai Medical Center
P28: Single-cell imaging mass cytometry identifies phenotypic subsets of Gastroenteropancreatic Neuroendocrine Tumors
Location:C110
Alexander Xu
Xu, Bin
Memorial Sloan Kettering
34: High Tumor Grade Predicts Somatic/Germline RET Mutation Status and Greater Regional Lymph Node Burden in Medullary Thyroid Carcinoma
Location:Georgia Ballroom
Bin Xu
Xu, Nucleus H
University of Pennsylvania
8: A high pre-existing TCR repertoire diversity may predict response to preoperative radiotherapy and pembrolizumab in early-stage breast cancer – NCT04454528 preliminary results
Location:Georgia Ballroom
Nucleus H Xu
Xu, Yi
University of North Carolina at Chapel Hill
48: Highly Sensitive Low Input Methylated Digital Droplet PCR Assay for Pancreatic Adenocarcinoma Molecular Subtyping
Location:C101
Yi Xu
Xynos, Ioannis
AstraZeneca
90: Pathological complete response to FLOT chemotherapy with or without durvalumab in resectable gastric and gastroesophageal junction cancer: subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
Ioannis Xynos
